Mesodiaminopimelate dehydrogenase and application thereof
The use of meso-diaminopimelate dehydrogenase enzymes from Firmicutes bacterium and Novibacillus thermophilus, combined with a three-enzyme cascade reaction, addresses inefficiencies in D-aspartic acid synthesis, achieving high-purity and cost-effective production.
Patent Information
- Application Number
- CN202310635061.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-31
- Publication Date
- 2024-12-03
AI Technical Summary
Current methods for synthesizing D-aspartic acid are inefficient, costly, and result in low optical purity, limiting its industrial application.
Utilization of meso-diaminopimelate dehydrogenase enzymes from Firmicutes bacterium and Novibacillus thermophilus, along with a three-enzyme cascade reaction involving oxaloacetate synthase, formate dehydrogenase, and glucose dehydrogenase, to catalyze the synthesis of D-aspartic acid.
Achieves a green, efficient, and low-cost production of high-purity D-aspartic acid, with conversion rates up to 93%, suitable for industrial applications.
Smart Images

Figure CN119061089A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and relates to a meso-diaminopimelate dehydrogenase and application thereof. Background Art
[0002] D-aspartic acid plays an important role in the fields of medicine and cosmetics. Using D-aspartic acid and amoxicillin as raw materials, aspirin with a long half-life and low serum protein binding rate can be synthesized. D-aspartic acid can resist oxidation and promote the production of collagen, reducing the formation of wrinkles and rough skin.
[0003] The current enzymatic synthesis of D-aspartic acid is mainly through chiral resolution. It has been reported that meso-diaminopimelate dehydrogenase can reduce and aminize short-chain 2-keto acids such as pyruvate with high stereoselectivity to synthesize the corresponding D-amino acid. For example, CN115786296A discloses a meso-diaminopimelate dehydrogenase mutant, which can efficiently catalyze oxaloacetate to produce D-aspartic acid. Compared with the wild type, the specific enzyme activity for oxaloacetate can be increased by about 10.9 times; N-acyl-D-amino acid amidohydrolase can stereospecifically catalyze the hydrolysis of N-acyl-D-amino acids to produce D-amino acids and fatty acids. The enzyme has been applied to the synthesis of D-aspartic acid; D-succinamide Enzymes can hydrolyze N-succinyl-D-amino acids to generate succinic acid and D-amino acids. D-succinamidase can be used to synthesize D-aspartic acid using N-succinyl-DL-aspartic acid as a substrate, but its disadvantages are obvious, such as low yield and low optical purity of the product. L-amino acid oxidase can resolve mixed amino acids to obtain D-amino acids, and the products often have high optical purity. Among them, L-aspartate oxidase (EC1.4.3.16) is used to synthesize D-aspartic acid, but its theoretical yield is only 50%, which limits the industrial application of L-amino acid oxidase in synthesizing D-amino acids.
[0004] In summary, discovering new enzymes for the synthesis of D-aspartic acid and achieving efficient and low-cost production of D-aspartic acid are of great significance for the application field of D-aspartic acid. Summary of the invention
[0005] In view of the deficiencies of the prior art and actual needs, the present invention provides a meso-diaminopimelate dehydrogenase and an application thereof. The present invention explores a meso-diaminopimelate dehydrogenase having catalytic activity for oxaloacetate to achieve efficient and low-cost production of D-aspartic acid.
[0006] To achieve the above object, the present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides an application of an enzyme in catalyzing oxaloacetate, wherein the enzyme is meso-diaminopimelate dehydrogenase, and the amino acid sequence of the enzyme includes the sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0008] In the present invention, it is discovered for the first time that the meso-diaminopimelate dehydrogenase DAPDH1 (amino acid sequence is SEQ ID NO.1, AccessionNumer is NLN19466.1) derived from Firmicutes bacterium and the meso-diaminopimelate dehydrogenase DAPDH2 (amino acid sequence is SEQ ID NO.2, AccessionNumer is WP_077718924.1) derived from Novibacillus thermophilus have catalytic activity for oxaloacetate, can catalyze the synthesis of D-aspartic acid, and have broad application prospects.
[0009] It can be understood that the present invention has found that the enzyme DAPDH1 derived from Firmicutes bacterium and the enzyme DAPDH2 derived from Novibacillus thermophilus have the function of catalyzing the synthesis of D-aspartic acid from oxaloacetate. Therefore, enzymes in Firmicutes bacterium, Novibacillus thermophilus or similar strains with similar sequences and functions identical or similar to the sequence shown in SEQ ID NO.1 or SEQ ID NO.2 can be expected to have the function of catalyzing oxaloacetate. In addition, enzymes obtained by replacing, deleting or adding one or at least two amino acid residues to the sequence shown in SEQ ID NO.1 or SEQ ID NO.2 using general technical means in the field, and having the same or similar functions as the original protein, can also be expected to have the function of catalyzing oxaloacetate.
[0010] SEQ ID NO.1:
[0011] MALDNRLRVAIIGYGNVGRYALKAVQAAPDMLLTGVVRRDPKTPQPSELAGVKVVSDIRELPDTEGALLCLPTRLIPQWAERILSMGINTVDGYDIHGELADLRQRLHQVAQRAGSVAVLSCGWDPGTNSIVRALFELMAPRGITYTNYGP GMSLGHTVAVKAIPGVKDALSVTIPDGMGVHKRAVYVELEPGADFQAIAEAIKSDPYFVNDETKVTQVEDVENLIDMGQGVFLERKGVSSETDNQLFRYDIRINNPALTAQIMTASLRAASRQKPGCYTMLEIPVIDFLPGERESLIRRLV.
[0012] SEQ ID NO.2:
[0013] MNKVHKIAVVGYGNIGKYAVQALNRAPDMELAGVVRRARSARDVPPELAGVPIATSIDELEGVEAAILATPTRTTPEYASDILSKGIHTVDSYDIHGELADVRRKLDDIAKRHGSVAIVSAGWDPGTDSMIRSMLEFMAPGGVTYTNFGPG MSMGHSVAVKAIDGVKDALSMTIPLGTGVHRRMVYVECEAGADFETVKEKVLADPYFVNDETHVIQVDDVQQLVDVGQGVSMERKGVSGATHNQLFNFEMRINNPALTSQVLVAAARATFKQQPGAYTMIEVPIIDFMYGDREELIKRLV.
[0014] In a second aspect, the present invention provides use of the enzyme described in the first aspect in synthesizing D-aspartic acid.
[0015] In a third aspect, the present invention provides a method for synthesizing D-aspartic acid, the method comprising:
[0016] Oxaloacetate is used as a substrate and the enzyme described in the first aspect is used as a catalyst to catalyze the production of D-aspartic acid.
[0017] Preferably, the method comprises:
[0018] Oxaloacetate, NADP + The mixture is mixed with the enzyme described in the first aspect and reacted to obtain D-aspartic acid.
[0019] Preferably, the oxaloacetate, NADP+ The mass concentration ratio of the catalyst is 1:0.1:(1~2.5).
[0020] Preferably, the reaction temperature is 20-40°C, including but not limited to 21°C, 22°C, 23°C, 25°C, 30°C, 35°C, 36°C, 38°C or 39°C, and the reaction time is 15-25h.
[0021] Preferably, the method further comprises the step of coenzyme cycling, wherein the coenzyme cycling comprises:
[0022] Formate dehydrogenase and / or glucose dehydrogenase are added to the reaction system.
[0023] In the present invention, the steps of designing the coenzyme cycle can further recycle the coenzyme, reduce the cost, and improve the substrate conversion rate.
[0024] It is understood that formate dehydrogenase or glucose dehydrogenase commonly used in the art are suitable for the present invention. For example, formate dehydrogenase FDH from Enterococcus faecalis can be selected, and the Accession Number of the amino acid sequence is ESU74154.1.
[0025] In a fourth aspect, the present invention provides a method for synthesizing D-aspartic acid, the method comprising:
[0026] L-aspartic acid and / or mixed aspartic acid are used as substrates, and oxaloacetate synthase and the enzyme described in the first aspect are used as catalysts to catalyze the production of D-aspartic acid.
[0027] The oxaloacetate synthetase includes L-amino acid deaminase and / or L-aspartate aminotransferase.
[0028] It is understood that L-amino acid deaminase or L-aspartate aminotransferase commonly used in the art are applicable to the present invention. For example, the L-amino acid deaminase or L-aspartate aminotransferase can be selected from any of the following (a1)-(a14):
[0029] (a1) L-amino acid deaminase LAAD1 from Proteus mirabilis, with the amino acid sequence Accession Number AVK70349.1;
[0030] (a2) L-amino acid deaminase LAAD2 from Bordetella pertussis, with the amino acid sequence Accession Number WP_010929992.1;
[0031] (a3) L-amino acid deaminase LAAD3 from Proteus mirabilis, with the Accession Number of the amino acid sequence being ACD36582.1;
[0032] (a4) L-amino acid deaminase LAAD4 from Proteus vulgaris, with the amino acid sequence AccessionNumer being WP_198620890.1;
[0033] (a5) L-amino acid deaminase LAAD5 from Proteus myxofaciens, with the amino acid sequence AccessionNumer being WP_066749310.1;
[0034] (a6) L-aspartate aminotransferase LAT1 from Chromobacterium sp., with the amino acid sequence AccessionNumer being WP_235089119.1;
[0035] (a7) L-aspartate aminotransferase LAT2 from Vogesella mureinivorans, with the amino acid sequence AccessionNumer being WP_147694092.1;
[0036] (a8) L-aspartate aminotransferase LAT3 from Neisseriaceae bacterium, with the amino acid sequence AccessionNumer MBP6117209.1;
[0037] (a9) L-aspartate aminotransferase LAT4 from Laribacter hongkongensis, with the amino acid sequence AccessionNumer being WP_239859084.1;
[0038] (a10) L-aspartate aminotransferase LAT5 from Arabidopsis thaliana, with an amino acid sequence Accession Number of NP_850022.1;
[0039] (a11) L-aspartate aminotransferase LAT6 from Daucus carota, with an amino acid sequence Accession Number of AAA33134.1;
[0040] (a12) L-aspartate aminotransferase LAT7 from Pseudomonasfluorescens SBW25, with the AccessionNumer of the amino acid sequence being CAI2798637.1;
[0041] (a13) L-aspartate aminotransferase LAT8 from Fructobacillus tropaeoli, with an amino acid sequence Accession Number of GAP03629.1;
[0042] (a14) L-aspartate aminotransferase LAT9 from anaerobic bacteria (Bacillus mycoides), with the Accession Number of the amino acid sequence being EEL71638.1.
[0043] Preferably, the method comprises:
[0044] L-aspartate and / or mixed aspartate, oxaloacetate synthase, NADP + The mixture is mixed with the enzyme described in the first aspect and reacted to obtain D-aspartic acid.
[0045] Preferably, the method further comprises the step of coenzyme cycling, wherein the coenzyme cycling comprises:
[0046] Formate dehydrogenase and / or glucose dehydrogenase are added to the reaction system.
[0047] In the present invention, a one-pot method is used to carry out a three-enzyme cascade reaction of the excavated meso-diaminopimelate dehydrogenase, L-amino acid deaminase (or L-aspartate aminotransferase), and formate dehydrogenase (or glucose dehydrogenase), so that cheap racemic aspartic acid or L-aspartic acid can be completely converted into high-value-added D-aspartic acid (the reaction schematic diagram is shown in FIG. Figure 1 and Figure 2 It is green, environmentally friendly and efficient, and has broad industrial application prospects.
[0048] Compared with the prior art, the present invention has the following beneficial effects:
[0049] The present invention discovers that the enzyme DAPDH1 derived from Firmicutes bacterium and the enzyme DAPDH2 derived from Novibacillus thermophilus have the function of catalyzing the synthesis of D-aspartic acid from oxaloacetate, and designs a method for synthesizing D-aspartic acid, thereby achieving green, environmentally friendly, efficient and low-cost preparation of D-aspartic acid, which has broad industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] Figure 1 Schematic diagram of the reaction for preparing D-aspartic acid by L-amino acid deaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase;
[0051] Figure 2 Schematic diagram of the reaction for preparing D-aspartate by L-aspartate aminotransferase, meso-diaminopimelate dehydrogenase and formate dehydrogenase;
[0052] Figure 3 This is the liquid chromatogram of D-aspartic acid standard product;
[0053] Figure 4 Liquid chromatograms of D-aspartate prepared for meso-diaminopimelate dehydrogenase and formate dehydrogenase using oxaloacetate as substrate;
[0054] Figure 5 This is the liquid chromatogram of L-aspartic acid standard product;
[0055] Figure 6 Liquid chromatograms of D-aspartate were prepared for L-amino acid deaminase, meso-diaminopimelate dehydrogenase, and formate dehydrogenase using L-aspartate as substrate. DETAILED DESCRIPTION
[0056] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.
[0057] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0058] Example 1
[0059] In this example, engineered bacteria expressing L-amino acid deaminase, engineered bacteria expressing L-aspartate aminotransferase, engineered bacteria expressing meso-diaminopimelate dehydrogenase, and engineered bacteria expressing formate dehydrogenase were prepared.
[0060] The coding genes of L-amino acid deaminase (LAAD1-LAAD5), L-aspartate transaminase (LAT1-LAT9), meso-diaminopimelate dehydrogenase (DAPDH1 or DAPDH2) and formate dehydrogenase (AccessionNumer of amino acid sequence is ESU74154.1) are sent to Qingke Biotechnology Co., Ltd. for synthesis (codon optimization is performed with Escherichia coli as host as needed), and the synthesized genes are connected to the expression vector for construction. The vector is specifically pET30a, and the small DNA fragment between the enzyme recognition sites NdeI and BamHI of pET30a is replaced with the coding genes of the relevant enzymes after full gene synthesis to obtain a recombinant expression vector, and the above recombinant expression vector is transformed into E.coli BL (DE3).
[0061] Example 2
[0062] This example describes the expression of L-amino acid deaminase, L-aspartate transaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase, and the preparation of whole cells and crude enzyme powder.
[0063] The recombinant expression plasmid constructed in Example 1 was transformed into Escherichia coli BL21 (DE3) competent cells to obtain recombinant cells.
[0064] The transformants were picked up and placed in 5 mL of LB liquid medium containing 50 mg / L kanamycin, and cultured at 37°C and 220 rpm for 6 h. The cultured bacterial liquid was inoculated into 100 mL of LB medium (containing 50 mg / L kanamycin) at a 5% inoculum, and cultured at 37°C and 220 rpm for about 2 h until the OD 600 When the concentration of the protein reaches 0.6, IPTG is added to a final concentration of 0.5 mM, and the shake flask is placed in a shaker for 16 h at 25°C and 220 rpm. Centrifuge at 4°C and 8000 rpm for 10 minutes, collect the precipitated bacteria, and resuspend the bacteria except LAAD1-LAAD5 in phosphate buffer (100 mM, pH 7.5) to obtain a bacterial suspension; then, ultrasonically disrupt the bacterial cells in an ice bath to obtain a crude enzyme solution of the disrupted sample.
[0065] The crude enzyme solution was centrifuged at 4°C and 10,000 rpm for 25 minutes, the supernatant was collected, frozen at -80°C, and then freeze-dried in a vacuum dryer to obtain crude enzyme powder.
[0066] Example 3
[0067] In this embodiment, L-aspartate is catalyzed by L-amino acid deaminase or L-aspartate aminotransferase to generate oxaloacetate from L-aspartate.
[0068] The whole cells of L-amino acid deaminase prepared in Example 2 or crude enzyme powder of L-aspartate aminotransferase were used to catalyze L-aspartate to produce oxaloacetate.
[0069] When L-amino acid deaminase whole cells are used as a catalyst, PBS buffer (pH 9.0) with a concentration of 100 mM, L-aspartic acid with a final concentration of 5 mg / mL, and L-amino acid deaminase whole cells (wet bacterial weight) with a final concentration of 20 mg / mL are added to the reaction system in sequence. After the reaction system is placed at 30° C. for 20 hours, the product is detected by liquid chromatography.
[0070] When crude L-aspartate aminotransferase powder is used as a catalyst, PBS buffer (pH 9.0) with a concentration of 100 mM, L-aspartic acid with a final concentration of 5 mg / mL, crude L-aspartate aminotransferase powder with a final concentration of 2 mg / mL, 2-ketoglutaric acid with a final concentration of 10 mg / mL and PLP with a final concentration of 0.5 mg / mL are added to the reaction system in sequence. After the reaction system is placed at 30°C for 20 hours, the product is detected by liquid chromatography.
[0071] The detection conditions of liquid chromatography are as follows: chromatographic column (ChiralAAOA4.6*150mm, 5um); column temperature is 25°C; mobile phase is 10mM copper sulfate aqueous solution / isopropanol=95% / 5%; flow rate is 1mL / min; injection volume is 5μL; running time is 25 minutes.
[0072] The conversion rate results of L-aspartate to oxaloacetate catalyzed by L-amino acid deaminase or L-aspartate aminotransferase are shown in Table 1. The results show that some L-amino acid deaminase and all L-aspartate aminotransferases can catalyze L-aspartate to oxaloacetate with a conversion rate of 0-93%.
[0073] Table 1
[0074] name Conversion rate (%) name Conversion rate (%) LAAD1 19 LAT3 41 LAAD2 3 LAT4 38 LAAD3 21 LAT5 39 LAAD4 0 LAT6 22 LAAD5 93 LAT7 18 LAT1 44 LAT8 41 LAT2 47 LAT9 32
[0075] Note: Conversion rate = (A2-A1) / A2*100%; the peak area of L-aspartic acid detected by liquid chromatography of the sample after the conversion experiment is A1; the peak area of L-aspartic acid detected by liquid chromatography of the same concentration of L-aspartic acid-free enzyme reaction solution is A2; the conversion rate of the enzyme is determined by the consumption of L-aspartic acid.
[0076] Example 4
[0077] In this example, crude meso-diaminopimelate dehydrogenase powder is used to catalyze oxaloacetate to produce D-aspartic acid.
[0078] The crude enzyme powder of meso-diaminopimelate dehydrogenase prepared in Example 2 was used to catalyze oxaloacetate to produce D-aspartic acid.
[0079] Add ammonium formate / ammonia buffer (pH 9) with a final concentration of 0.9 M, oxaloacetic acid with a final concentration of 5 mg / mL, and NADP with a final concentration of 2 mg / mL to the reaction system. + Dependent formate dehydrogenase enzyme powder, NADP with a final concentration of 0.5 mg / mL + and crude meso-diaminopimelate dehydrogenase powder with a final concentration of 5 mg / mL, and the reaction system was reacted at 30° C. for 20 hours, and the product was detected by liquid chromatography.
[0080] The detection conditions of liquid chromatography are as follows: chromatographic column (ChiralAAOA4.6*150mm, 5um); column temperature is 25°C; mobile phase is 10mM copper sulfate aqueous solution / isopropanol=95% / 5%; flow rate is 1mL / min; injection volume is 5μL; running time is 25 minutes.
[0081] The detection spectrum of D-aspartic acid standard is as follows Figure 3 As shown, the HPLC detection result of DAPDH1 and formate dehydrogenase FDH coupling catalyzing oxaloacetate to produce D-aspartate is shown in Figure 4 shown.
[0082] The conversion rate results of oxaloacetate to D-aspartic acid by coupling meso-diaminopimelate dehydrogenase with formate dehydrogenase are shown in Table 2. The results show that the meso-diaminopimelate dehydrogenase mined by the present invention can catalyze oxaloacetate to D-aspartic acid.
[0083] Table 2
[0084]
[0085]
[0086] Note: Conversion rate = (A1+A2) / A3*100%; the peak area of D-aspartic acid detected by liquid chromatography after the conversion experiment is A1, and the peak area of L-aspartic acid is A2; the peak area of aspartic acid detected by liquid chromatography of the same concentration of D-aspartic acid enzyme-free reaction solution or L-aspartic acid enzyme-free reaction solution is A3; the conversion rate of the enzyme is judged by the amount of D-aspartic acid generated. ee (stereoselectivity) = (A1-A2) / (A1+A2)*100%.
[0087] Example 5
[0088] In this example, a cascade reaction of L-amino acid deaminase or L-aspartate transaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase is performed to catalyze L-aspartate to produce D-aspartate.
[0089] When coupled with L-amino acid deaminase, ammonium formate / ammonia buffer (pH 9) with a final concentration of 0.9 M, L-aspartic acid with a final concentration of 5 mg / mL, L-amino acid deaminase whole cells (wet bacteria weight) with a final concentration of 20 mg / mL, and NADP with a final concentration of 2 mg / mL were added to the reaction system in sequence. + Dependent formate dehydrogenase enzyme powder, NADP with a final concentration of 0.5 mg / mL + and crude meso-diaminopimelate dehydrogenase powder with a final concentration of 5 mg / mL. After the reaction system was reacted at 30° C. for 20 hours, the product was detected by liquid chromatography.
[0090] When coupled with L-aspartate aminotransferase, add ammonium formate / ammonia buffer (pH 9) with a final concentration of 0.9 M, L-aspartic acid with a final concentration of 5 mg / mL, crude L-aspartate aminotransferase powder with a final concentration of 2 mg / mL, 2-ketoglutaric acid with a final concentration of 10 mg / mL, PLP with a final concentration of 0.5 mg / mL, and NADP with a final concentration of 2 mg / mL in the reaction system. + Dependent formate dehydrogenase enzyme powder, NADP with a final concentration of 0.5 mg / mL + and crude meso-diaminopimelate dehydrogenase powder with a final concentration of 5 mg / mL. After the reaction system was reacted at 30° C. for 20 hours, the product was detected by liquid chromatography.
[0091] The detection conditions of liquid chromatography are as follows: chromatographic column (ChiralAAOA4.6*150mm, 5um); column temperature is 25°C; mobile phase is 10mM copper sulfate aqueous solution / isopropanol=95% / 5%; flow rate is 1mL / min; injection volume is 5μL; running time is 25 minutes.
[0092] The detection spectrum of L-aspartic acid standard is as follows Figure 5 As shown, the HPLC detection result of LAAD5, DAPDH1 and FDH coupling catalyzing L-aspartate to produce D-aspartate is shown in Figure 6 shown.
[0093] The conversion rate results of the cascade reaction of L-aspartic acid to D-aspartic acid catalyzed by L-amino acid deaminase or L-aspartate transaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase are shown in Table 3. The results show that L-amino acid deaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase can catalyze L-aspartic acid to D-aspartic acid with a maximum conversion rate of 37%. L-amino acid transaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase can catalyze L-aspartic acid to D-aspartic acid, but there is residual L-aspartic acid.
[0094] Table 3
[0095]
[0096] Note: Conversion rate = A1 / A3*100%; the peak area of D-aspartic acid detected by liquid chromatography after the conversion experiment is A1, and the peak area of L-aspartic acid is A2; the peak area of aspartic acid detected by liquid chromatography for the same concentration of D-aspartic acid-free enzyme reaction solution is A3; the conversion rate of the enzyme is judged by the amount of D-aspartic acid generated; the proportion of L-aspartic acid in the product = A2 / (A1+A2), the proportion of D-aspartic acid = A1 / (A1+A2).
[0097] Example 6
[0098] In this example, different amounts of meso-diaminopimelate dehydrogenase and formate dehydrogenase were added to catalyze the cascade reaction of oxaloacetate to generate D-aspartic acid, and L-amino acid deaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase were added to catalyze the cascade reaction of L-aspartic acid to generate D-aspartic acid.
[0099] When using oxaloacetate as substrate for the two-enzyme cascade reaction, add ammonium formate / ammonia buffer (pH 9) with a final concentration of 0.9 M, oxaloacetate with a final concentration of 5 mg / mL, and NADP with a final concentration of 2 mg / mL to the reaction system in sequence. + Dependent formate dehydrogenase enzyme powder, NADP with a final concentration of 0.5 mg / mL + and different final concentrations of crude meso-diaminopimelate dehydrogenase powder (5 mg / mL, 7.5 mg / mL, 10 mg / mL and 12.5 mg / mL), the reaction system was reacted at 30°C for 20 hours, and the product was detected by liquid chromatography.
[0100] When L-aspartic acid was used as substrate for the three-enzyme cascade reaction, ammonium formate / ammonia buffer (pH 9) with a final concentration of 0.9 M, L-aspartic acid with a final concentration of 5 mg / mL, L-amino acid deaminase whole cells (wet bacteria weight) with a final concentration of 20 mg / mL, and NADP with a final concentration of 2 mg / mL were added to the reaction system in sequence.+ Dependent formate dehydrogenase enzyme powder, NADP with a final concentration of 0.5 mg / mL + and crude meso-diaminopimelate dehydrogenase powder with a final concentration of 12.5 mg / mL. After the reaction system was reacted at 30° C. for 20 hours, the product was detected by liquid chromatography.
[0101] The detection conditions of liquid chromatography are as follows: chromatographic column (ChiralAAOA4.6*150mm, 5um); column temperature is 25°C; mobile phase is 10mM copper sulfate aqueous solution / isopropanol=95% / 5%; flow rate is 1mL / min; injection volume is 5μL; running time is 25 minutes.
[0102] The conversion rates of oxaloacetate to D-aspartate catalyzed by the cascade reaction of meso-diaminopimelate dehydrogenase and formate dehydrogenase in different amounts, and L-aspartate to D-aspartate catalyzed by the cascade reaction of L-amino acid deaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase are shown in Table 4. The results show that when oxaloacetate is used as the substrate, as the amount of meso-diaminopimelate dehydrogenase added increases, the conversion rate of oxaloacetate to D-aspartate increases. When the amount of meso-diaminopimelate dehydrogenase added is 12.5 mg / mL, the conversion rate is as high as 93%. The conversion rate of L-aspartate to D-aspartate catalyzed by L-amino acid deaminase, meso-diaminopimelate dehydrogenase and formate dehydrogenase is also improved to 90%.
[0103] Table 4
[0104]
[0105] Note: Conversion rate = A1 / A3*100%; the peak area of D-aspartic acid detected by liquid chromatography after the conversion experiment is A1, and the peak area of L-aspartic acid is A2; the peak area of aspartic acid detected by liquid chromatography for the same concentration of D-aspartic acid-free enzyme reaction solution is A3; the conversion rate of the enzyme is judged by the amount of D-aspartic acid generated; the proportion of L-aspartic acid in the product = A2 / (A1+A2), the proportion of D-aspartic acid = A1 / (A1+A2).
[0106] In summary, the present invention discovers that the enzyme DAPDH1 derived from Firmicutes bacterium and the enzyme DAPDH2 derived from Novibacillus thermophilus have the function of catalyzing the synthesis of D-aspartic acid from oxaloacetate, and designs a method for synthesizing D-aspartic acid. The one-pot method is used to carry out a three-enzyme cascade reaction of the excavated meso-diaminopimelate dehydrogenase, L-amino acid deaminase (or L-aspartate transaminase), and formate dehydrogenase (or glucose dehydrogenase), so that cheap racemic aspartic acid or L-aspartic acid can be completely converted into high-value-added D-aspartic acid, thereby realizing green, environmentally friendly, efficient and low-cost preparation of D-aspartic acid, and having broad industrial application prospects.
[0107] The applicant declares that the present invention illustrates the detailed method of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed method, that is, it does not mean that the present invention must rely on the above-mentioned detailed method to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
Claims
1. Use of an enzyme in catalyzing oxaloacetate, wherein the enzyme is meso-diaminopimelate dehydrogenase; The amino acid sequence of the enzyme includes the sequence shown in SEQ ID NO.1 or SEQ ID NO.
2.
2. Use of the enzyme described in claim 1 in the synthesis of D-aspartic acid.
3. A method for synthesizing D-aspartic acid, characterized in that: The method comprises: Oxaloacetate is used as a substrate and the enzyme described in claim 1 is used as a catalyst to catalyze the production of D-aspartic acid.
4. The method for synthesizing D-aspartic acid according to claim 3, characterized in that: The method comprises: Oxaloacetate, NADP + The mixture is mixed with the enzyme according to claim 1 and reacted to obtain D-aspartic acid.
5. The method for synthesizing D-aspartic acid according to claim 4, characterized in that: The oxaloacetate, NADP + The mass concentration ratio of the catalyst is 1:0.1:(1~2.5).
6. The method for synthesizing D-aspartic acid according to claim 4 or 5, characterized in that: The reaction temperature is 20-40°C and the reaction time is 15-25h.
7. The method for synthesizing D-aspartic acid according to any one of claims 3 to 6, characterized in that: The method further comprises the step of coenzyme cycling, wherein the coenzyme cycling comprises: Formate dehydrogenase and / or glucose dehydrogenase are added to the reaction system.
8. A method for synthesizing D-aspartic acid, characterized in that: The method comprises: Using L-aspartic acid and / or mixed aspartic acid as substrates, using oxaloacetate synthase and the enzyme described in claim 1 as catalysts to catalyze the production of D-aspartic acid; The oxaloacetate synthetase includes L-amino acid deaminase and / or L-aspartate aminotransferase.
9. The method for synthesizing D-aspartic acid according to claim 8, characterized in that: The method comprises: L-aspartate and / or mixed aspartate, oxaloacetate synthase, NADP + The mixture is mixed with the enzyme according to claim 1 and reacted to obtain D-aspartic acid.
10. The method for synthesizing D-aspartic acid according to claim 8 or 9, characterized in that: The method further comprises the step of coenzyme cycling, wherein the coenzyme cycling comprises: Formate dehydrogenase and / or glucose dehydrogenase are added to the reaction system.
